StonvexLoading…
StonvexStonvexStonvexCore line items from FFIV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.63B | $822.47M | $3.09B | $2.28B |
Operating Income | $393.20M | $214.19M | $765.95M | $560.30M |
Net Income | $327.81M | $180.05M | $692.38M | $501.89M |
EPS (Diluted) | $5.68 | $3.10 | $11.80 | $8.54 |
Total Assets | $6.50B | $6.29B | $6.32B | $6.11B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.44B | $1.20B | $1.34B | $1.43B |
Free Cash Flow OCF − CapEx | $497.06M | $149.49M | $906.41M | $714.48M |
Shares Outstanding | 56.75M | 56.89M | 57.68M | 57.87M |